Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31089
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBindila, Laura-
dc.contributor.authorEid, Tore-
dc.contributor.authorMills, James D-
dc.contributor.authorHildebrand, Michael S-
dc.contributor.authorBrennan, Gary P-
dc.contributor.authorMasino, Susan A-
dc.contributor.authorWhittemore, Vicky-
dc.contributor.authorPerucca, Piero-
dc.contributor.authorReid, Christopher A-
dc.contributor.authorPatel, Manisha-
dc.contributor.authorWang, Kevin K-
dc.contributor.authorvan Vliet, Erwin A-
dc.date2022-
dc.date.accessioned2022-11-04T05:05:28Z-
dc.date.available2022-11-04T05:05:28Z-
dc.date.issued2022-10-18-
dc.identifier.citationEpilepsia Open 2022en
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31089-
dc.description.abstractThe International League Against Epilepsy/American Epilepsy Society (ILAE/AES) Joint Translational Task Force established the TASK3 working groups to create common data elements (CDEs) for various preclinical epilepsy research disciplines. This is the second in a two-part series of omics papers, with the other including genomics, transcriptomics and epigenomics. The aim of the CDEs is to improve the standardization of experimental designs across a range of epilepsy research related methods. We have generated CDE tables with key parameters and case report forms (CRFs) containing the essential contents of the study protocols for proteomics, lipidomics and metabolomics of samples from rodent models and people with epilepsy. We discuss the important elements that need to be considered for the proteomics, lipidomics and metabolomics methodologies, providing a rationale for the parameters that should be documented.en
dc.language.isoeng
dc.subjectcase report formen
dc.subjectlipidomeen
dc.subjectmetabolomeen
dc.subjectomic data processingen
dc.subjectpreclinicalen
dc.subjectproteomeen
dc.subjectrodenten
dc.titleA companion to the preclinical common data elements for proteomics, lipidomics and metabolomics data in rodent epilepsy models. A Report of the TASK3-WG4 Omics Working Group of the ILAE/AES Joint Translational Task Force.en
dc.typeJournal Articleen
dc.identifier.journaltitleEpilepsia Openen
dc.identifier.affiliationMurdoch Children's Research Institute, The Royal Children's Hospital, Parkville, Victoria, Australiaen
dc.identifier.affiliationClinical Lipidomics Unit, Institute of Physiological Chemistry, University Medical Center of the Johannes Gutenberg University of Mainz, Mainz, Germany..en
dc.identifier.affiliationEpilepsy Research Centreen
dc.identifier.affiliationBladin-Berkovic Comprehensive Epilepsy Program, Austin Health, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDepartment of Neuroscience, Central Clinical School, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Neurology, The Royal Melbourne Hospital, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Neurology, Alfred Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationThe Florey Institute of Neuroscience and Mental Healthen
dc.identifier.affiliationDepartment of Laboratory Medicine, Yale School of Medicine, New Haven, Connecticut, USA..en
dc.identifier.affiliationAmsterdam UMC, University of Amsterdam, Dept (Neuro)Pathology, Amsterdam Neuroscience, Amsterdam, the Netherlands..en
dc.identifier.affiliationUCD School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland.. FutureNeuro Research Centre, Royal College of Surgeons in Ireland, Dublin, Ireland..en
dc.identifier.affiliationNeuroscience Program and Psychology Department, Life Sciences Center, Trinity College, Hartford, Connecticut, USA..en
dc.identifier.affiliationDivision of Neuroscience, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA..en
dc.identifier.affiliationDepartment of Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA..en
dc.identifier.affiliationProgram for Neurotrauma, Neuroproteomics & Biomarker Research (NNBR), Department of Emergency Medicine, Psychiatry and Neuroscience, University of Florida, Gainesville, Florida, USA.. Brain Rehabilitation Research Center, Malcom Randall VA Medical Center, North Florida/South Georgia Veterans Health System, Gainesville, Florida, USA..en
dc.identifier.doi10.1002/epi4.12662en
dc.type.contentTexten
dc.identifier.orcid0000-0001-9217-6393en
dc.identifier.orcid0000-0003-4237-4900en
dc.identifier.orcid0000-0002-7855-7066en
dc.identifier.orcid0000-0002-1457-8028en
dc.identifier.orcid0000-0001-5747-3202en
dc.identifier.pubmedid36259125
local.name.researcherHildebrand, Michael S
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptNeurology-
crisitem.author.deptComprehensive Epilepsy Program-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Feb 22, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.